Search results
Results From The WOW.Com Content Network
On July 8, 2010, Alcon's independent director committee (IDC) had set up a $50 million litigation trust to ensure company's minority shareholders get the best deal from bidder Novartis AG. [15] On April 9, 2019, Alcon completed a 100% spin-off from Novartis. [4] [16] [17] The new standalone company is worth up to 28 billion Swiss francs. [18]
Novartis is the world's first largest in life sciences and agribusiness markets. [6] It is also the second-largest pharmaceutical company by market cap in 2019. [126] Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [127]
This is a list of websites that are blocked in Singapore. Under the responsibility of the Infocomm Media Development Authority (IMDA), these websites are mainly unlicensed gambling, pimping (known as vice related activities), copyright infringement/piracy, and for spreading falsehoods. Some websites may be blocked as suspected scam websites. [1]
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
By John Miller ZURICH (Reuters) - Swiss eyecare company Alcon made its debut on the SIX Swiss Exchange on Tuesday with a market capitalisation of more than $25 billion after a shareholder spin-off ...
For premium support please call: 800-290-4726 more ways to reach us
Official website. DealStreetAsia is a Singapore-based financial news website, founded in 2014 by Joji Thomas Philip. It is a financial news platform tracking private equity, venture capital activity, deal flows, initial public offers, investments, fund-raising, startups and targets to be the go-to destination portal for deal activity in Asia.
The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double-digit sales growth, plus $350 million in cost It now expects more bang for its buck from Alcon.